Pharma Ed’s Pre-filled Syringes & Injection Devices 2025 in La Jolla brings together experts to examine advances in digital health, connected devices, and next-generation combination product development for parenteral delivery. Ypsomed’s Reto Falk will present “Device options for treating obesity with incretins – Balancing patient preference, sustainability, and cost,” offering fresh insights into an evolving and highly dynamic therapy area.
We’re pleased to contribute to this year’s programme and look forward to engaging with peers across the field. See you in California.
Our speaker at the conference
Reto Falk
Reto Falk, Director in Account & Business Development for Ypsomed. He holds an MBA with Edinburgh Business School. Reto is an account executive and team leader with extensive experience driving growth as a partner of MedTech, pharmaceutical and biotech companies. He joined Ypsomed in 2020 with a focus on business development fostering and expanding the company’s global customer base. Reto has more than 25 years of experience in global sales and marketing roles with MedTech providers, including Straumann, Camlog and Geistlich Pharma representing global leaders in the field of dental implants and hard/soft tissue regeneration.
